MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
IBRO Neuroscience Reports
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

83 results · 1 filter active ·
Results by year
20212025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
83 works in the cohort · of 4,299,418page 1 of 2

Labels cover 0 of 83 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 83 of 83 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study
Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Subramaniam Srinivasan, Subramanian Pushkala, Sudhakar S Bharatidasan, Nobunao Ikewaki +4 more
2023· article· en· IBRO Neuroscience Reports· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
16
citations
affunlabeled
EXAMINING THE ENGRAM ENCODING SPECIFICITY HYPOTHESIS IN MICE
Jung Hoon Jung, Ying Wang, Andrew J. Mocle, Andrew Chung, Stefan Köhler, Paul W. Frankland +1 more
2023· article· en· IBRO Neuroscience Reports· Pharmacology, Toxicology and Pharmaceutics
distilled prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]
Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Subramaniam Srinivasan, Subramanian Pushkala, Sudhakar S Bharatidasan, Nobunao Ikewaki +4 more
2023· erratum· en· IBRO Neuroscience Reports· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
1
citations
affunlabeled
LONG-TERM Β2 ADRENERGIC AGONIST TREATMENT INCREASES LIFE SPAN AND AMELIORATE MOTOR IMPAIRMENT IN A MYASTHENIA MODEL WITH SPECIFIC VACHT DELETION IN MOTOR NEURONS (MN-VACHT-KD)
Barbara Mota, Leonardo Rossi, Priscila Aparecida Costa Valadão, Matheus P.S. Magalhães-Gomes, Bruna Andressa dos Santos Oliveira, Vânia F. Prado +3 more
2023· article· en· IBRO Neuroscience Reports· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
0
citations
next →

How this was built: Screen · Findings · About